Pizarro D
National Children's Hospital, Social Security System, San José, Costa Rica.
Drugs. 1988;36 Suppl 4:39-47. doi: 10.2165/00003495-198800364-00007.
Diarrhoeal diseases are the major cause of infant mortality in developing countries. Dehydration is the most common complication of diarrhoea, and severe dehydration causes up to 80% of diarrhoeal fatalities. For more than 100 years, physicians focused the treatment of diarrhoeal diseases on the symptom diarrhoea, and there were many 'antidiarrhoeal' drugs, such as water adsorbents (kaolin and pectin) and antiperistaltics (opium, paregoric elixir, diphenoxylate hydrochloride with atropine sulphate and loperamide). This approach focused on a non-dangerous symptom and diverted attention from the real killer, dehydration. A few decades ago, only severely dehydrated patients were treated by intravenous therapy. This treatment was prescribed by a group of professional health workers, administered intravenously by skilled nurses, and reserved for the few patients resident near health facilities. Oral rehydration therapy (ORT), developed 20 years ago, has several advantages over intravenous therapy; it can be administered at home, at health clinics or in modern hospitals, by parents or by nurses or physicians. Most serum disturbances in dehydrated neonates, infants, children, adults and the elderly are resolved by this treatment.
腹泻病是发展中国家婴儿死亡的主要原因。脱水是腹泻最常见的并发症,严重脱水导致高达80%的腹泻死亡病例。100多年来,医生们将腹泻病的治疗重点放在腹泻症状上,有许多“止泻”药物,如水吸附剂(高岭土和果胶)和抗蠕动剂(鸦片、复方樟脑酊、盐酸地芬诺酯与硫酸阿托品合剂以及洛哌丁胺)。这种方法关注的是一种无危险的症状,却将注意力从真正的杀手——脱水上转移开了。几十年前,只有严重脱水的患者才接受静脉治疗。这种治疗由一组专业医护人员开出处方,由技术熟练的护士进行静脉注射,而且只针对居住在医疗机构附近的少数患者。20年前研发的口服补液疗法(ORT)相对于静脉治疗有几个优点;它可以由家长或护士或医生在家中、健康诊所或现代医院进行。这种治疗能解决脱水新生儿、婴儿、儿童、成人和老年人中大多数的血清紊乱问题。